Tags Investors

Investors

Which pure-play marijuana stock will have the highest operating margin?

12/1/17--The pure-play marijuana stock expected to have the highest operating margin on the entire pot industry will likely derive from cannabinoid-based drug developer GW Pharmaceuticals. GW Pharmaceuticals' experimental drug Epidiolex easily found the mark in numerous pivotal-stage clinical trials involving two rare types of childhood-onset epilepsy. If approved, Epidiolex could generate in the neighborhood of $500 million in peak annual sales giving it the highest operating margin of all pot stocks by the end of the decade. Read

Big-name investors pour millions into marijuana — both medicinal and not

8/28/17--Wealthy investors are pouring tens of millions into the cannabis industry in a bid to capitalize on the gold rush that’s expected when California legalizes recreational marijuana on Jan. 1. They’re backing development of new medicinal products, such as cannabis-infused skin patches; new methods for vaporizing and inhaling; and “budtender” apps, which promises to scour 750 strains of cannabis and use lab research, including DNA analysis of each strain, to help customers find the perfect match. Read

Marijuana sector leaders say they’ve met with TMX Group to discuss U.S. investments

6/12/17--Marijuana industry insiders say they have met with TMX Group, the operators of Canada's largest stock exchange, to devise a policy on investing in the U.S., where growing and selling cannabis violates federal laws. However, TMX Group would not confirm that it is holding meetings with the marijuana sector in order to formulate a policy regarding U.S. investments, saying in an email that it does not comment on "individual issuer affairs." Read

L.A. investor is betting $100 million on legal weed

5/26/17--Beverly Hills real estate firm Starpoint Properties said it plans to invest $100 million in California marijuana companies over the next 12 months. Starpoint CEO Paul Daneshrad's vehicle for cannabis investing is Stargreen Capital, a subsidiary of the original business drawing on the same assets, investors, and expertise. The firm is looking to invest up to $15 million in companies that, "Have a mindset to really get aggressive and capture market share," Daneshrad said. Read

Who cares what Jeff Sessions does? These marijuana stocks should soar

4/2/17--Although questions and concerns exist about whether or not U.S. Attorney General Jeff Sessions will crack down on marijuana sales in states that have legalized the drug, two marijuana stocks won't be impacted by what Sessions does: Aurora Cannabis and Canopy Growth Corporation. Both stocks are performing well in 2017 so far and appear to be headed much higher. Read

Investor hopes to help others cash in on growing marijuana business

screen-shot-2016-12-05-at-7-05-56-am11/20/16--Kyle Kazan, real estate investor and chief executive of Long?Beach-based Beach Front Property Management, Inc., has taken a lead role in creating a fund for those who want a piece of California’s marijuana industry. Kazan anticipates the maturation of the marijuana industry will attract additional investors with business experience, but for now, it’s his view that there is not yet enough capital for all of the potential investment opportunities related to cannabis. Read

As more states legalize marijuana, investors and marketers line up

screen-shot-2016-12-04-at-10-35-26-pm11/20/16--According to Brendan Kennedy, CEO of the marijuana-focused private equity firm Privateer Holdings, there's been a surge of interest from investors since the passage of the eight ballot measures. The marijuana market has some unique characteristics that make it attractive to investors, but the big draw is the fledgling legal market for marijuana being around $7 billion, according to New Frontier and ArcView Market Research. Read

4 best marijuana stocks to play the green rush

screen-shot-2016-11-10-at-10-40-15-am11/5/16--Zacks Investment Research has selected four cannabis linked stocks that are poised to benefit from the legalization of marijuana. These stocks also boast a Zacks Rank #1 (Strong Buy) or 2 (Buy): GW Pharmaceuticals,  The Scotts Miracle-Gro Company,  Pepsico, Inc., and Philip Morris International, Inc.. Read

Privateer raises $40M, exceeds $100M in total funding

fb-square-english-spanish11/4/16--Privateer Holdings, a cannabis-focused private equity firm in Seattle, announced Friday it has closed on $40 million in convertible bridge financing, bringing its fundraising total to $122 million. Privateer said it will use the money to launch new ventures, make strategic acquisitions, and expand its three existing portfolio companies into new markets. Read

Damian Marley invests in marijuana futures

screen-shot-2016-10-24-at-8-50-28-am10/11/16--Singer Damian Marley, who has opened a massive dispensary in Colorado at Mile High Stadium, is collaborating with Ocean Grown Extracts, and a part of their joint venture is to turn a vacant Coalinga, California prison into a medical marijuana manufacturing plant, which Ocean Grown will use to sell wholesale to dispensaries. Marley’s initial interest was born out of his fondness for Ocean Grown, but the scope and details of the venture came after the two started working together. Read

SEC accuses marijuana-focused company, CEO of fraud

fb-square-english-spanish10/4/16--The Securities and Exchange Commission has filed fraud charges against Infinex Ventures and its CEO Ronald Salem, alleging they falsely claimed to have secured $100 million to finance marijuana businesses. The SEC also claims the company reported more than $500,000 in revenue for the second quarter of 2014, when in reality it didn’t have “any operations, revenue or funding.” Read

Conference promises ‘brutally honest’ advice on getting into the business

screen-shot-2016-10-05-at-10-27-46-am9/22/16--On Friday, the editors of the Denver-based Marijuana Business Daily are setting up shop at the Marriott hotel in Center City for what it calls its Crash Course. Eight hours of workshops will offer guidance to aspiring players who want to know how the industry works. Read

Cannabis attracting mainstream research analysts

screen-shot-2016-10-05-at-10-20-55-am9/22/16--Cowen and Company joins the ranks of the few mainstream research firms to officially begin covering the cannabis industry. A comprehensive 100 plus page report with contributions from ten different analysts was issued by Cowen Washington Research Group on September 12. Read

Ganjapreneurs pitch 200 marijuana investors at investment event

screen-shot-2016-10-02-at-7-06-54-pm9/16/16--During the Investor Pitch Forum, hosted by the cannabis industry investment and research firm The Arcview Group, some 200 investors Arcview described as “high net worth” met with dozens of companies looking to cash in on the promising new market of legal recreational marijuana. Read